The third Data Science Insights talk will take place at Imperial College, London on 12 May at 5pm. Click here to register to attend.
The supply chains that feed the world and transport all our goods are global. But they are fragile; vulnerable to climate change, extreme weather, natural disaster, wars and political unrest. As the global population heads towards 8 billion, one of the biggest challenges we face is feeding ourselves. Thomson Reuters recently predicted that advances in genetically modified foods and advances in agricultural technology will make food shortages and price fluctuations a thing of the past by 2025.
Beyond the limits of supply
The world’s population is graying as it grows – the number of people over 65 will more than double by 2050, contributing significantly to the rise in dementia cases. The estimated annual worldwide costs of dementia is at least $604 billion and projected to rise to $1 trillion by 2030. In some high-income countries, one-third to one-half of people with dementia live in resource -and cost- intensive residential or nursing homes. 62% of people with dementia live in developing countries, which is expected to rise to 71% by 2050.
The search for causes and cures:
Perhaps nowhere is the importance of “knowing why” more apparent than in the interplay of world energy markets and the increasing urgency of climate and environmental issues. Today’s graphic, from our 2014 Annual report, overlays the number of renewable energy inventions with price of oil.
Sources: Thomson Reuters Derwent World Patents Index, Thomson Reuters Web of Science and Thomson Reuters Datastream
From the most popular topics in research to a list of countries with the greatest scientific impact, today’s graphic takes a look at some of the hottest research topics around the world.
See how EndNote moves you through the research process as you search, organize, write, publish and share and start a free trial.
2014 was a year in which knowing more —who, what, why and how — was critical to informed decision making and successful outcomes. Explore our 2014 Annual Report.
Perhaps nowhere is the importance of “knowing why” more apparent than in the interplay of world energy markets and the increasing urgency of climate and environmental issues. See how through context, connection and insight, we help professionals know why changes are occurring in world energy, identify and develop alternatives, and monitor the environmental impacts of energy: (more…)
Our customers participate in the most important conversations in a fast and complex world every day. As professionals, they navigate markets, risks and regulations; shape and manage legal systems and tax jurisdictions; protect innovations; and drive scientific discovery. Their work is important and their decisions matter. And common to them all is the need to know.
Professionals today need more. More than information, data and news. More than speed. More than mobile access. They need insight, analysis and context. Solutions that simplify, clarify and deliver competitive advantage, providing confidence to act on what they know. And millions of professionals from every part of the global economy rely on Thomson Reuters for what they need to know to understand critical issues, solve tough problems and adapt to dynamic change.
During 2014, the risks of global fraud and rising terrorism; the multi-stage recovery of world markets and the opening up of China; the significant shift in oil prices and increasingly urgent focus on climate change and energy alternatives; and the economic and social impacts of an aging world population and Alzheimer’s disease were just a few of the challenges and opportunities facing our world. It was a year in which knowing more — who, what, why and how — was critical to informed decision making and successful outcomes.
Explore our 2014 Annual Report – Know which includes the Corporate Responsibility & Inclusion and Thomson Reuters Foundation annual reports.
In January 2014, Thomson Reuters Cortellis Competitive Intelligence named three drugs to watch that were expected to enter the market that year and make sales of over $1 billion within five years. All three entered the market as anticipated, and although the Cortellis Consensus sales forecasts have fluctuated over the course of the year, all of the drugs are still forecast to be $1 billion-plus blockbusters.
Compared with 2014, there are more potential blockbusters expected to enter the market this year. The majority of them are forecast to have 2019 sales of between $1 billion and $3 billion, although three drugs are set to exceed this, with the following 2019 sales forecasts: Bristol-Myers Squibb’s (BMS) melanoma drug Opdivo (nivolumab) at $5.684 billion; Regeneron Pharmaceuticals and Sanofi’s Praluent (alirocumab) for hypercholesterolemia at $4.414 billion; and Novartis’ LCZ-696 (sacubitril and valsartan) for chronic heart failure at $3.731 billion: (more…)
In the fourth installment of Wait, What? the team discuss the “science fact” that has come from the science fiction of Star Trek, Star Wars, Total Recall, comics, and other media. The show starts with a comparison of the devices that were used in the Star Trek universe of television and movies, and how we’re seeing many of those ideas and concepts come to fruition. The guys then get into the concept of 3-D printing and synthetic biology. The discussion then shifts to Jason and Joe announcing that they’ve created the “Inertia-jet” (patent pending), that will revolutionize travel, and what it must feel like to be the first person/people to test a potentially dangerous piece of technology.
The team spend much of the second half of the show in a “lightning round” discussing different sci-fi influencers to include Star Wars, James Bond, Disney, and comic books. Most importantly they discuss if we currently are at a stagnation point in technological improvements to our lives. This spawns a great discussion about time travel!
As always, stick around after the music at the end of the show for something extra.
Thomson Reuters Metrics Mania, a unique competition that measures the research impact of the the 68 institutions competing in the 2015 NCAA Men’s Basketball Tournament, will align those same schools in six rounds of weekly competition to determine the final winner of the Research Crown. Winners will be identified by reports pulled from Thomson Reuters InCites.
The competition will begin Monday, March 16th and close with the naming of the champion on Tuesday, April 7th. Fans are invited to submit brackets with their predictions of the winners beginning March 16. Participants will be awarded one point for each correct guess. At the conclusion of the contest, the 10 entrants with the most points will each be awarded a $100 American Express Gift Card.
Get notified when brackets are available.
Follow Metrics Mania on Twitter @InCites_TR and join the conversation at #metricsmania.
The improbability principle says that we should expect identical lottery numbers to come up more than once, lightning to strike twice, and financial crashes to occur. It says that apparently improbable events are actually commonplace. At Thomson Reuters we provide the information that our customers use to help them make many types of prediction and judgment – and we know that there is a clear benefit in predicting something unexpected that your competitor hasn’t.
At our second Data Science Insights event, chaired by Reuters Lead Anchor Axel Threlfall, Professor David Hand, Emeritus Professor at Imperial College London, spoke on the subject of his book, “The Improbability Principle”. Professor David Hand points to five laws that together make up ‘The Improbability Principle,’ and can lead to dramatic miscalculation when predicting how likely something is to happen.
The Law of Selection